| CCI-779 |
| 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate] rapamycin |
| (CAS 162635-04-3) |
 |
| Description： |
Rapamycin (Item No. 13346) is an immunosuppressant that specifically interacts with the cytosolic FK-binding protein 12 to form a complex which inhibits the mammalian target of rapamycin (mTOR) pathway by directly binding to mTOR Complex 1. Temsirolimus is a dihydroxymethyl propionic acid ester of rapamycin with improved solubility that specifically inhibits mTOR signaling with a potency similar to that of rapamycin. Treatment with temsirolimus leads to cell cycle arrest in the G1 phase and also inhibition of tumor angiogenesis by reducing synthesis of VEGF. Temsirolimus demonstrates cytostatic activity in several xenograft models of human tumors in nude mice, including glioblastomas, prostate carcinoma, pancreatic, liver, and breast cancers, and medulloblastoma.
|
| Product No. |
KT00248 |
| Product Name |
CCI-779 |
| Synonyms |
Temsirolimus |
| Formal Name |
42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate] rapamycin |
| CAS Number |
162635-04-3 |
| Molecular Formula |
C56H87NO16 |
| Formula Weight |
1030.3 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
AZD-8055
AZD2014
BEZ235
ETP-46464
GDC-0349
GDC-0980
GNE-477
GNE-493
|
|
